tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market
Advertisement

Resmed (RMD) Technical Analysis

Compare
1,142 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Resmed’s (RMD) Moving Averages Convergence Divergence (MACD) indicator is -4.74, suggesting Resmed is a Sell.
Resmed’s (RMD) 20-Day exponential moving average is 251.11, while Resmed’s (RMD) share price is $250.75, making it a Sell.
Resmed’s (RMD) 50-Day exponential moving average is 258.89, while Resmed’s (RMD) share price is $250.75, making it a Sell.

Resmed (RMD) Pivot Points

Nov 24, 2025, 12:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
236.46
239.13
241.53
244.20
246.60
249.27
251.67
Fibonacci
239.13
241.07
242.27
244.20
246.14
247.34
249.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Resmed (RMD) Moving Averages

Nov 24, 2025, 12:31 AM
Period
Simple
Exponential
MA5
246.12Buy
247.30Buy
MA10
248.08Buy
247.92Buy
MA20
249.25Buy
251.11Sell
MA50
262.78Sell
258.89Sell
MA100
267.91Sell
260.74Sell
MA200
250.93Sell
251.23Sell
Resmed’s (RMD) 10-Day exponential moving average is 247.92, while Resmed’s (RMD) share price is $250.75, making it a Buy.
Resmed’s (RMD) 100-Day exponential moving average is 260.74, while Resmed’s (RMD) share price is $250.75, making it a Sell.
Resmed’s (RMD) stock price is $250.75 and Resmed’s (RMD) 50-day simple moving average is 262.78, creating a Sell signal.
Resmed’s (RMD) stock price is $250.75 and Resmed’s (RMD) 100-day simple moving average is 267.91, creating a Sell signal.
Resmed’s (RMD) stock price is $250.75 and Resmed’s (RMD) 200-day simple moving average is 250.93, creating a Sell signal.

Resmed (RMD) Technical Indicators

Nov 24, 2025, 12:31 AM
Name
Value
Implied Action
RSI (14)
45.77
Neutral
STOCH (9,6)
31.90
Neutral
STOCHRSI (14)
36.97
Neutral
MACD (12,26)
-4.74
Sell
ADX (14)
33.38
Neutral
Williams %R
-36.51
Buy
CCI (14)
-4.61
Neutral
ATR (14)
6.27
-
Ultimate Oscillator
46.21
Neutral
ROC
0.96
Buy
Resmed’s (RMD) Relative Strength Index (RSI) is 45.77, creating a Neutral signal.
Resmed’s (RMD) Trend Strength Indicator (ADX) is 33.38, creating a Neutral signal.
Resmed’s (RMD) Commodity Channel Index (CCI) is -4.61, creating a Neutral signal.
Resmed’s (RMD) Price Rate of Change (ROC) is 0.96, creating a Buy signal.

FAQ

Is RMD a Buy, Hold, or Sell?
Based on RMD’s technical indicators, RMD is a Hold.
    What is RMD’s RSI (14)?
    RMD’s RSI (14) is 45.77, which suggests RMD is a Neutral.
      What is RMD’s MACD?
      RMD’s MACD is -4.74, which suggests RMD is a Sell.
        What is RMD’s 5-day moving average?
        RMD’s 5-day moving average is 246.12, which suggests RMD is a Buy.
          What is RMD’s 20-day moving average?
          RMD 20-day moving average is 249.25, which suggests RMD is a Buy.
            What is RMD’s 50-day moving average?
            RMD’s 50-day moving average is 262.78, which suggests RMD is a Sell.
              What is RMD’s 200-day moving average?
              RMD’s 200-day moving average is 250.93, which suggests RMD is a Sell.
                What is RMD’s Williams % R (14)?
                RMD’s Williams % R (14) is -36.51, which suggests RMD is a Buy.
                  What is RMD’s CCI (14)?
                  RMD’s CCI (14) is -4.61, which suggests RMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis